Comparison between Three Promising ß-emitting Radionuclides, ⁶⁷Cu, ⁴⁷Sc and ¹⁶¹Tb, with Emphasis on Doses Delivered to Minimal Residual Disease

Abstract

(161)Tb can effectively irradiate small tumors thanks to its decay spectrum that combines medium-energy β(-) emission and low-energy conversion and Auger electrons. Therefore (161)Tb might be a better candidate than (67)Cu and (47)Sc for treating minimal residual disease in a clinical setting.